We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$842M
AUM Growth
+$160M
(+23%)
Cap. Flow
+$179M
Cap. Flow
% of AUM
21.25%
Top 10 Holdings %
Top 10 Hldgs %
32.27%
Holding
254
New
89
Increased
38
Reduced
24
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$12.6M |
| 2 |
Wells Fargo
WFC
|
+$12.2M |
| 3 |
Huntington Bancshares
HBAN
|
+$11.7M |
| 4 |
Exelon
EXC
|
+$11.1M |
| 5 |
Peabody Energy
BTU
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$12.4M |
| 2 |
Truist Financial
TFC
|
+$8.47M |
| 3 |
Progressive
PGR
|
+$8.43M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$8.1M |
| 5 |
Cboe Global Markets
CBOE
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.59% |
| 2 | Technology | 20.4% |
| 3 | Healthcare | 19.9% |
| 4 | Utilities | 11.57% |
| 5 | Industrials | 11.26% |
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2023 Portfolio in Review
As of Q1 2023, Crestline Management held 254 positions worth $842M, up 23% from $682M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Crestline Management deployed $179M of net new capital in Q1 2023, opening 89 new positions and adding to 38 existing holdings. Its largest new stake was TSMC: 140,000 shares worth $13M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Denali Therapeutics, an estimated $12.4M trimmed.
- Crestline Management's largest Q1 2023 buy was TSMC: 140,000 shares worth $13M.
- Crestline Management added most to Wells Fargo in Q1 2023, an estimated $12.2M increase.
- Crestline Management's biggest Q1 2023 reduction was Denali Therapeutics, cutting an estimated $12.4M.
- Crestline Management fully exited Progressive in Q1 2023, selling an estimated $8.43M.
- Crestline Management's ten largest holdings make up 32% of its $842M portfolio in Q1 2023.
- Crestline Management opened 89 new positions and closed 97 in Q1 2023.
- Crestline Management's portfolio value rose 23% quarter-over-quarter to $842M.
Based on Crestline Management's 13F filing for Q1 2023, filed 15 May 2023.